How big is the U.S. small molecule innovator API CDMO market?

The U.S. small molecule innovator API CDMO market size was estimated at USD 8.80 billion in 2024 and is expected to reach USD 9.41 billion in 2025.

What is the U.S. small molecule innovator API CDMO market growth?

The U.S. small molecule innovator API CDMO market is expected to grow at a compound annual growth rate of 6.01% from 2025 to 2030 to reach USD 12.60 billion by 2030.

Which segment accounted for the largest U.S. small molecule innovator API CDMO market share?

The clinical segment dominated the U.S. small molecule innovator API CDMO market, with a share of 54.68% in 2024. The segment's growth is owing to rising early-phase R&D activity, demand for rapid scale-up, and outsourcing preference by small to mid-sized pharmaceutical companies. In addition, CDMOs offering integrated development, regulatory support, and flexible batch production are crucial partners in accelerating timelines, managing costs, and navigating complex clinical trial requirements.

Who are the key players in the U.S. small molecule innovator API CDMO market?

Some key players operating in the U.S. small molecule innovator API CDMO market include Lonza Group Ltd., Novo Holdings (Catalent, Inc.), Thermo Fisher Scientific, Inc., Siegfried Holding AG, Recipharm AB, CordenPharma International, Samsung Biologics, Labcorp, Ajinomoto Bio-Pharma Services, Piramal Pharma Solutions, and Jubilant Life Sciences (Jubilant Biosys Limited).

What are the factors driving the U.S. small molecule innovator API CDMO market?

Key factors that are driving the market growth include increasing demand for complex and high-potency APIs, accelerated drug development timelines, stringent regulatory requirements, and a growing preference for outsourcing among pharmaceutical innovators. Technological advancements, rising focus on quality and compliance, and the need for scalable, cost-efficient manufacturing solutions further boost the overall market growth and strategic CDMO partnerships.

U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Report

U.S. Small Molecule Innovator API CDMO Market (2025 - 2030) Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Service, By Customer Type, By Therapeutic Area, By Region, And Segment Forecasts

Market Segmentation

U.S. Small Molecule Innovator API CDMO Market, by Stage Type (Revenue, USD Million, 2018 - 2030)
- Preclinical
- Clinical
  - Phase I
  - Phase II
  - Phase III
- Commercial
U.S. Small Molecule Innovator API CDMO Market, by Service (Revenue, USD Million, 2018 - 2030)
- Process Development
  - Preclinical Development
  - Clinical Development
  - Scale-up Optimization
- Contract Manufacturing
  - Clinical
  - Commercial
- Analytical Testing and Quality Control
- Packaging and Supply Chain Solutions
- Others
U.S. Small Molecule Innovator API CDMO Market, by Customer Type (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical
  - Small
  - Medium
  - Large
- Biotechnology
  - Small
  - Medium
  - Large
U.S. Small Molecule Innovator API CDMO Market, by Therapeutic Area (Revenue, USD Million, 2018 - 2030)
- Cardiovascular Diseases
- Oncology
- Respiratory Disorders
- Neurology
- Metabolic Disorders
- Infectious Diseases
- Others
U.S. Small Molecule Innovator API CDMO Market: Regional Outlook (Revenue, USD Million, 2018 - 2030)
- Northeast
  - Northeast Small Molecule Innovator API CDMO Market, by Stage Type
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Northeast Small Molecule Innovator API CDMO Market, by Service
    - Process Development
      - Preclinical Development
      - Clinical Development
      - Scale-up Optimization
    - Contract Manufacturing
      - Clinical
      - Commercial
    - Analytical Testing and Quality Control
    - Packaging and Supply Chain Solutions
    - Others
  - Northeast Small Molecule Innovator API CDMO Market, by Customer Type
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Biotechnology
      - Small
      - Medium
      - Large
  - Northeast Small Molecule Innovator API CDMO Market, by Therapeutic Area
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - New Jersey
    - New Jersey Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - New Jersey Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - New Jersey Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - New Jersey Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - New York
    - New York Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - New York Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - New York Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - New York Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Massachusetts
    - Massachusetts Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Massachusetts Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - Massachusetts Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Massachusetts Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- Midwest
  - Midwest Small Molecule Innovator API CDMO Market, by Stage Type
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Midwest Small Molecule Innovator API CDMO Market, by Service
    - Process Development
      - Preclinical Development
      - Clinical Development
      - Scale-up Optimization
    - Contract Manufacturing
      - Clinical
      - Commercial
    - Analytical Testing and Quality Control
    - Packaging and Supply Chain Solutions
    - Others
  - Midwest Small Molecule Innovator API CDMO Market, by Customer Type
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Biotechnology
      - Small
      - Medium
      - Large
  - Midwest Small Molecule Innovator API CDMO Market, by Therapeutic Area
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - Illinois
    - Illinois Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Illinois Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - Illinois Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Illinois Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Missouri
    - Missouri Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Missouri Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - Missouri Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Missouri Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - North Carolina
    - North Carolina Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - North Carolina Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - North Carolina Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - North Carolina Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- West Group
  - West Group Small Molecule Innovator API CDMO Market, by Stage Type
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - West Group Small Molecule Innovator API CDMO Market, by Service
    - Process Development
      - Preclinical Development
      - Clinical Development
      - Scale-up Optimization
    - Contract Manufacturing
      - Clinical
      - Commercial
    - Analytical Testing and Quality Control
    - Packaging and Supply Chain Solutions
    - Others
  - West Group Small Molecule Innovator API CDMO Market, by Customer Type
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Biotechnology
      - Small
      - Medium
      - Large
  - West Group Small Molecule Innovator API CDMO Market, by Therapeutic Area
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - California
    - California Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - California Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - California Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - California Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Washington
    - Washington Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Washington Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - Washington Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Washington Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- South
  - South Small Molecule Innovator API CDMO Market, by Stage Type
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - South Small Molecule Innovator API CDMO Market, by Service
    - Process Development
      - Preclinical Development
      - Clinical Development
      - Scale-up Optimization
    - Contract Manufacturing
      - Clinical
      - Commercial
    - Analytical Testing and Quality Control
    - Packaging and Supply Chain Solutions
    - Others
  - South Small Molecule Innovator API CDMO Market, by Customer Type
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Biotechnology
      - Small
      - Medium
      - Large
  - South Small Molecule Innovator API CDMO Market, by Therapeutic Area
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - Texas
    - Texas Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Texas Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - Texas Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Texas Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Florida
    - Florida Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Florida Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - Florida Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Florida Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Georgia
    - Georgia Small Molecule Innovator API CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Georgia Small Molecule Innovator API CDMO Market, by Service
      - Process Development
        
        Preclinical Development
        
        Clinical Development
        
        Scale-up Optimization
      - Contract Manufacturing
        
        Clinical
        
        Commercial
      - Analytical Testing and Quality Control
      - Packaging and Supply Chain Solutions
      - Others
    - Georgia Small Molecule Innovator API CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Georgia Small Molecule Innovator API CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments